R, A., Z, Y., O, D., P, B., Y, J., S, B., . . . MJ, B. (2026). Prescription Trends of Hydrochlorothiazide vs. Chlorthalidone in the United States (2019-2024). American journal of hypertension, 39(3), 459. https://doi.org/10.1093/ajh/hpaf190
Chicago Style (17th ed.) CitationR, Asante, Yao Z, Dzaye O, Berning P, Jelwan Y, Burka S, Blumenthal RS, and Blaha MJ. "Prescription Trends of Hydrochlorothiazide Vs. Chlorthalidone in the United States (2019-2024)." American Journal of Hypertension 39, no. 3 (2026): 459. https://doi.org/10.1093/ajh/hpaf190.
MLA (9th ed.) CitationR, Asante, et al. "Prescription Trends of Hydrochlorothiazide Vs. Chlorthalidone in the United States (2019-2024)." American Journal of Hypertension, vol. 39, no. 3, 2026, p. 459, https://doi.org/10.1093/ajh/hpaf190.